Medical use
MY200304AInactive Publication Date: 2023-12-19VALIRX
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- MYPI2018000452
- Authority / Receiving Office
- MY · MY
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2011-11-01
- Filing Date
- 2012-11-01
- Publication Date
- 2023-12-19
- Estimated Expiration
- Not applicable · inactive patent
Abstract
The invention provides a molecule that inhibits or prevents an interaction between a Src family kinase and an androgen or estradiol receptor, for use in preventing or treating a non-cancerous condition in which an activity of AR and / or ER is a contributory factor in a subject, or for use in preventing or treating a cancerous condition in which an activity of AR and / or ER is a contributory factor in a subject who wishes to preserve fertility, or for use in preventing or treating a gynaecological condition in which an activity of AR and / or ER is a contributory factor in a subject. Preferably, the molecule comprises or consists of the structure: B,-[(Pro)"-X1.His-Pro-His-Ala-Arg-Ile-Lys]*-Rp, or 81-[flys-ile-arg-ala-his-pro-his-x,-(pro),].- Rp, or a derivative or fragment thereof, wherein B is a first chemical moiety, j is 0 or l, n is an integer from 1-10, X is any amino acid, r is an integer from 0 to 2, m is an integer from I to 3, R is a second chemical moiety, p is 0 or 1, and [lys-ile-arg-ala-his-pro-his-xr.-(pro)n] is the retro-inverso peptide of [(Pro)n-Xr.-His-Pro-His-Ala-Arg-Ile-Lys]. (Figure 1)
Need to check novelty before this filing date? Find Prior Art
